|
|
||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Yamanashi Medical University, 1110 Shimokato, Tamaho, Nakakoma, Yamanashi 409-3815, Japan (T.I., H.S., T.A., A.S.A., T.Y., K.I.); and Department of Radiology, Kyorin University School of Medicine, Tokyo, Japan (H.H., J.H.). Received June 30, 2000; revision requested August 8; final revision received and accepted April 17, 2001. Address correspondence to T.I. (e-mail: ichikawa@res.yamanashi-med.ac.jp).
PURPOSE: To define the duct-penetrating sign at magnetic resonance (MR) cholangiopancreatography (MRCP) and to assess the usefulness of this sign for distinguishing an inflammatory pancreatic mass (IPM) from a conventional pancreatic carcinoma (CPC) compared with arterial phase computed tomography (hereafter, CT) and arterial phase MR imaging (hereafter, MR imaging).
MATERIALS AND METHODS: MRCP, CT, and MR images were compared by means of receiver operating characteristic (ROC) analysis for 11 IPMs and 43 CPCs. With the MRCP images, a morphologic classification of the main pancreatic duct (MPD) was attempted for all lesions. On the basis of this classification and the enhancement patterns of a lesion, all readers graded the presence of IPM or CPC on a five-point scale for all images.
RESULTS: On the MRCP images, the morphologic characteristics of the MPD were nonobstruction for IPM (28 of 33, 85%) and obstruction or irregular stenosis for CPC (124 of 129, 96%). At ROC analysis among all the techniques, MRCP images had the highest value (0.98) for significant areas under the ROC curve (CT, 0.84; MR, 0.76) (P < .001). For the duct-penetrating sign in the broad sense (nonobstructed MPD) and the sign in the narrow sense (only normal MPD), the sensitivity, specificity, and accuracy for diagnosis of IPM were 85%, 96%, and 94%, respectively, and 36%, 100%, and 87%, respectively.
CONCLUSION: The duct-penetrating sign on MRCP images was more helpful to distinguish IPM from CPC than were the enhancement patterns on CT and MR images.
Index terms: Pancreas, CT, 770.12113, 770.12115 Pancreas, MR, 770.121411, 770.121412, 77.121415, 770.12143 Pancreas, neoplasms, 774.321 Pancreatitis, 770.291
This article has been cited by other articles:
![]() |
K. J. To'o, S. S. Raman, N. C. Yu, Y. J. Kim, T. Crawford, B. M. Kadell, and D. S. K. Lu Pancreatic and Peripancreatic Diseases Mimicking Primary Pancreatic Neoplasia RadioGraphics, July 1, 2005; 25(4): 949 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazumdar Group Sequential Design for Comparative Diagnostic Accuracy Studies: Implications and Guidelines for Practitioners Med Decis Making, October 1, 2004; 24(5): 525 - 533. [Abstract] [PDF] |
||||
![]() |
P Manoharan and M B Sheridan Neoplasms of the pancreas Imaging, September 1, 2004; 16(4): 323 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M K Kalra, M M Maher, P R Mueller, and S Saini State-of-the-art imaging of pancreatic neoplasms Br. J. Radiol., December 1, 2003; 76(912): 857 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Leyendecker, K. M. Elsayes, B. I. Gratz, and J. J. Brown MR Cholangiopancreatography: Spectrum of Pancreatic Duct Abnormalities Am. J. Roentgenol., December 1, 2002; 179(6): 1465 - 1471. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |